BioTime (BTX) Tops Q1 EPS

BioTime (NYSE: BTX) reported Q1 EPS of $0.30, $0.36 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $910 thousand.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)